Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB 452533 是TRPV1的选择性拮抗剂,pKb 为 7.8。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 348 | 现货 | ||
2 mg | ¥ 497 | 现货 | ||
5 mg | ¥ 797 | 现货 | ||
10 mg | ¥ 1,330 | 现货 | ||
25 mg | ¥ 2,590 | 现货 | ||
50 mg | ¥ 3,990 | 现货 | ||
100 mg | ¥ 5,680 | 现货 | ||
500 mg | ¥ 11,700 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 885 | 现货 |
产品描述 | SB 452533 is an antagonist of the vanilloid receptor 1(pKb: 7.8). |
靶点活性 | TRPV1:7.8(pKb) |
体外活性 | SB 452533 significantly reduced Capsaicin-induced phosphorylation of AMPK and CAMKK2[1]. |
体内活性 | Small dose Cap significantly reduced bleomycin-induced pulmonary fibrosis in mice and obviously reversed alveolar epithelial cells epithelial-mesenchymal transition (EMT) (the expression of E-cadherin and ZO-1 were increased(P<0.05 or P<0.01)and the expression of α-SMA and Vimentin were decreased (P<0.05 or P<0.01) after drugs treatment for 21 day, concomitantly with the increase the expressions of TRPV1 and CGRP (P<0.05 or P<0.01), and inhibiting ERK1/2 phosphorylation and eIF3a expression (P<0.05 or P<0.01). These effects of small dose Cap were abolished in the presence of TRPV1 receptor antagonist SB 452533[2]. |
分子量 | 376.29 |
分子式 | C18H22BrN3O |
CAS No. | 459429-39-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 50 mg/ml(132.876 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6575 mL | 13.2876 mL | 26.5752 mL | 66.4381 mL |
5 mM | 0.5315 mL | 2.6575 mL | 5.315 mL | 13.2876 mL | |
10 mM | 0.2658 mL | 1.3288 mL | 2.6575 mL | 6.6438 mL | |
20 mM | 0.1329 mL | 0.6644 mL | 1.3288 mL | 3.3219 mL | |
50 mM | 0.0532 mL | 0.2658 mL | 0.5315 mL | 1.3288 mL | |
100 mM | 0.0266 mL | 0.1329 mL | 0.2658 mL | 0.6644 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SB 452533 459429-39-1 Membrane transporter/Ion channel TRP/TRPV Channel ATP glucose oxidation inhibit ERK1/2 TRPV1 pulmonary TRP Channel fibrosis CAMKK2 skeletal muscle capsaicin SB452533 Inhibitor SB-452533 Transient receptor potential channels inhibitor